izpis_h1_title_alt

Effect of humanizing mutations on the stability of the llama single-domain variable region
ID Soler, Miguel A. (Avtor), ID Medagli, Barbara (Avtor), ID Wang, Jiewen (Avtor), ID Oloketuyi, Sandra (Avtor), ID Bajc, Gregor (Avtor), ID Huang, He (Avtor), ID Fortuna, Sara (Avtor), ID De Marco, Ario (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (2,00 MB)
MD5: CC41A21EA3660B03A04F9B1BFCAC1F29
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2218-273X/11/2/163 Povezava se odpre v novem oknu

Izvleček
In vivo clinical applications of nanobodies (VHHs) require molecules that induce minimal immunoresponse and therefore possess sequences as similar as possible to the human VH domain. Although the relative sequence variability in llama nanobodies has been used to identify scaffolds with partially humanized signature, the transformation of the Camelidae hallmarks in the framework2 still represents a major problem. We assessed a set of mutants in silico and experimentally to elucidate what is the contribution of single residues to the VHH stability and how their combinations affect the mutant nanobody stability. We described at molecular level how the interaction among residues belonging to different structural elements enabled a model llama nanobody (C8WT, isolated from a naïve library) to be functional and maintain its stability, despite the analysis of its primary sequence would classify it as aggregation-prone. Five chimeras formed by grafting CDRs isolated from different nanobodies into C8WT scaffold were successfully expressed as soluble proteins and both tested clones preserved their antigen binding specificity. We identified a nanobody with human hallmarks that seems suitable for humanizing selected camelid VHHs by grafting heterologous CDRs in its scaffold and could serve for the preparation of a synthetic library of human-like single domains.

Jezik:Angleški jezik
Ključne besede:nanobody framework, modeling, nanobody humanization, CDR grafting
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:BF - Biotehniška fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:13 str.
Številčenje:Vol. 11, iss. 2, art. 163
PID:20.500.12556/RUL-134891 Povezava se odpre v novem oknu
UDK:577
ISSN pri članku:2218-273X
DOI:10.3390/biom11020163 Povezava se odpre v novem oknu
COBISS.SI-ID:48829955 Povezava se odpre v novem oknu
Datum objave v RUL:10.02.2022
Število ogledov:549
Število prenosov:118
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Biomolecules
Skrajšan naslov:Biomolecules
Založnik:MDPI
ISSN:2218-273X
COBISS.SI-ID:519952921 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:01.02.2021

Projekti

Financer:Drugi - Drug financer ali več financerjev
Program financ.:China, National Key Research and Development Program
Številka projekta:2019YFA0905600

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:N4-0046
Naslov:Identifikacija rekombinantnih nanotelesc za imunsko detekcijo eksosomov za diagnozo raka na dojkah

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J4-9322
Naslov:Razvoj reagentov za diagnostično stratificiranje in tarčno zdravljenje raka na dojki na osnovi tekočinskih biopsij

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Associazione Italiana per la Ricerca sul Cancro, My First AIRC grant
Številka projekta:18510

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj